BIOCORP: Full-Year 2022 Financial Results and Outlook for 20

Sales up 14% to €11.67 million Significant increase in operating expenses to €12.58 million (+20%) due to the growing internationalization of connected products activities Positive

Related Keywords

Issoire , Auvergne , France , Australia , Japan , United States , Denmark , Germany , Canada , Paris , France General , American , Danish , French , German , Atlantic Ocean , Merck Kga , Eric Dessertenne , Becton Dickinson , Sylvaine Dessard , Sanofi Solostar , Euronext , Merck Kgaa , Novo Nordisk , Research Tax Credit , Pfizer , Us Food Drug Administration , Tax Credit , Innovation Tax Credit , Intellectual Property , Drug Administration , German Merck , Securities Act , Communication Director , Biocorp , Bull , Ear , 022 , Financial , Results , Outlook , 023 ,